Yingqing Ran

Title: Yingqing Ran: Innovator in Pharmaceutical Compounds

Introduction: Yingqing Ran is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid forms of complex compounds. His work is characterized by a focus on innovative formulations that enhance the efficacy of therapeutic agents.

Latest Patents: Yingqing Ran holds a patent for "Solid forms of a compound," specifically for the compound designated as Compound I. This compound is identified as 2-(4-chlorophenoxy)-N-[3-[5-[cis-3-(trifluoromethoxy)cyclobutyl]-1,3,4-oxadiazol-2-yl]-1-bicyclo[1.1.1]pentanyl]acetamide. The patent details the preparation and characterization of this compound in the solid state, along with processes of manufacture and methods of using the forms of Compound I. He has 1 patent to his name.

Career Highlights: Yingqing Ran is currently employed at Denali Therapeutics Inc., where he continues to push the boundaries of pharmaceutical research. His work at Denali Therapeutics focuses on developing innovative treatments for neurological diseases, contributing to the advancement of medical science.

Collaborations: One of his notable coworkers is Christopher Rh Hale, with whom he collaborates on various projects within the pharmaceutical domain. Their combined expertise enhances the research and development efforts at Denali Therapeutics.

Conclusion: Yingqing Ran's contributions to the field of pharmaceuticals through his innovative patent work exemplify the impact of dedicated inventors in advancing medical science. His ongoing research at Denali Therapeutics Inc. continues to pave the way for new therapeutic solutions.